Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trinity Biotech is a commercial-stage diagnostics company with established point-of-care and clinical laboratory products. Q3 2025 revenue was $14.3 million with a 32% sequential increase, driven by TrinScreen HIV test sales[9]. The company achieved positive Adjusted EBITDA in Q3 2025[9], demonstrating improved financial performance from operational efficiencies and cost-reduction initiatives[3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trinity Biotech Investment.